Clinical features of chromosome 22q11.2 microdeletion syndrome in 208 Chilean patients

被引:22
作者
Repetto, G. M. [1 ,2 ]
Guzman, M. L. [1 ]
Puga, A. [1 ]
Calderon, J. F. [1 ]
Astete, C. P. [3 ]
Aracena, M. [3 ]
Arriaza, M.
Aravena, T. [4 ]
Sanz, P. [5 ]
机构
[1] Clin Alemana Univ Desarrollo, Fac Med, Ctr Genet Humana, Santiago 7710162, Chile
[2] Hosp Padre Hurtado, Santiago, Chile
[3] Hosp Ninos Luis Calvo Mackenna, Santiago, Chile
[4] Complejo Hosp Dr Sotero Rio, Santiago, Chile
[5] Univ Chile, Hosp Clin, Santiago, Chile
关键词
22q11; deletion; Chile; DiGeorge syndrome; velocardiofacial syndrome; CARDIO-FACIAL-SYNDROME; ANOMALY FACE SYNDROME; DIGEORGE-SYNDROME; DELETION SYNDROME; TBX1; POPULATION; PHENOTYPE; CHILDREN; DEFECTS; VARIABILITY;
D O I
10.1111/j.1399-0004.2009.01234.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Patients with chromosome 22q11 deletion syndrome exhibit significant phenotypic variability. Epidemiologic data suggest a higher incidence in Hispanics, but limited clinical information is available from Latin-American patients. We describe the clinical features of Chilean patients with 22q11 deletion syndrome and compare their findings with those reported in large European, Japanese and US series. Data were obtained from 208 patients from five medical centers. Mean age at diagnosis was 5.2 years, with a median of 2.3 years. Congenital heart defects were present in 59.6%, lower than other large series that averaged 75.8%. Palate abnormalities were present in 79%, higher than previous reports averaging 56%. Patients with congenital heart disease were diagnosed earlier (median 0.3 years of age) than those without heart defects (median 5.6 years) and had greater mortality attributable to the syndrome (9.8% vs 2.4%, respectively). The differences in frequencies of major anomalies may be due to growing awareness of more subtle manifestations of the syndrome, differences in clinical ascertainment or the presence of modifier factors. These observations provide additional data useful for patient counseling and for the proposal of health care guidelines.
引用
收藏
页码:465 / 470
页数:6
相关论文
共 50 条
  • [31] Practical Guidelines for Managing Patients with 22q11.2 Deletion Syndrome
    Bassett, Anne S.
    McDonald-McGinn, Donna M.
    Devriendt, Koen
    Digilio, Maria Cristina
    Goldenberg, Paula
    Habel, Alex
    Marino, Bruno
    Oskarsdottir, Solveig
    Philip, Nicole
    Sullivan, Kathleen
    Swillen, Ann
    Vorstman, Jacob
    [J]. JOURNAL OF PEDIATRICS, 2011, 159 (02) : 332 - U213
  • [32] Aortic Root Dilation in Patients With 22q11.2 Deletion Syndrome
    John, Anitha S.
    McDonald-McGinn, Donna M.
    Zackai, Elaine H.
    Goldmuntz, Elizabeth
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2009, 149A (05) : 939 - 942
  • [33] Microdeletion 22q11.2: an underdiagnosed genetic defect in psychiatric patients
    Leyhe, T
    Haarmeier, T
    Dufke, A
    Giedke, H
    [J]. NERVENARZT, 2002, 73 (05): : 452 - +
  • [34] A Patient With a De Novo Distal 22q11.2 Microdeletion and Anxiety Disorder
    Verhoeven, Willem
    Egger, Jos
    Brunner, Han
    de Leeuw, Nicole
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2011, 155A (02) : 392 - 397
  • [35] Chromosome 22q11.2 Deletion Syndrome: A Comprehensive Review of Molecular Genetics in the Context of Multidisciplinary Clinical Approach
    Szczawinska-Poplonyk, Aleksandra
    Schwartzmann, Eyal
    Chmara, Zuzanna
    Glukowska, Antonina
    Krysa, Tomasz
    Majchrzycki, Maksymilian
    Olejnicki, Maurycy
    Ostrowska, Paulina
    Babik, Joanna
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (09)
  • [36] Sclerocornea associated with the chromosome 22q11.2 deletion syndrome
    Binenbaum, Gil
    McDonald-McGinn, Donna M.
    Zackai, Elaine H.
    Walker, B. Michael
    Coleman, Karlene
    Mach, Amy M.
    Adam, Margaret
    Manning, Melanie
    Alcorn, Deborah M.
    Zabel, Carrie
    Anderson, Dennis R.
    Forbes, Brian J.
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2008, 146A (07) : 904 - 909
  • [37] Clinical and Immunological Defects and Outcomes in Patients with Chromosome 22q11.2 Deletion Syndrome
    Yu, Hsin-Hui
    Chien, Yin-Hsiu
    Lu, Meng-Yao
    Hu, Ya-Chiao
    Lee, Jyh-Hong
    Wang, Li-Chieh
    Lin, Yu-Tsan
    Yang, Yao-Hsu
    Chiang, Bor-Luen
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 2022, 42 (08) : 1721 - 1729
  • [38] Clinical and Immunological Defects and Outcomes in Patients with Chromosome 22q11.2 Deletion Syndrome
    Hsin-Hui Yu
    Yin-Hsiu Chien
    Meng-Yao Lu
    Ya-Chiao Hu
    Jyh-Hong Lee
    Li-Chieh Wang
    Yu-Tsan Lin
    Yao-Hsu Yang
    Bor-Luen Chiang
    [J]. Journal of Clinical Immunology, 2022, 42 : 1721 - 1729
  • [39] DiGeorge syndrome/chromosome 22q11.2 deletion syndrome.
    Sullivan K.E.
    [J]. Current Allergy and Asthma Reports, 2001, 1 (5) : 438 - 444
  • [40] 22q11.2 deletion syndrome in diverse populations
    Kruszka, Paul
    Addissie, Yonit A.
    McGinn, Daniel E.
    Porras, Antonio R.
    Biggs, Elijah
    Share, Matthew
    Crowley, T. Blaine
    Chung, Brian H. Y.
    Mok, Gary T. K.
    Mak, Christopher C. Y.
    Muthukumarasamy, Premala
    Thong, Meow-Keong
    Sirisena, Nirmala D.
    Dissanayake, Vajira H. W.
    Paththinige, C. Sampath
    Prabodha, L. B. Lahiru
    Mishra, Rupesh
    Shotelersuk, Vorasuk
    Ekure, Ekanem Nsikak
    Sokunbi, Ogochukwu Jidechukwu
    Kalu, Nnenna
    Ferreira, Carlos R.
    Duncan, Jordann-Mishael
    Patil, Siddaramappa Jagdish
    Jones, Kelly L.
    Kaplan, Julie D.
    Abdul-Rahman, Omar A.
    Uwineza, Annette
    Mutesa, Leon
    Moresco, Angelica
    Gabriela Obregon, Maria
    Richieri-Costa, Antonio
    Gil-da-Silva-Lopes, Vera L.
    Adeyemo, Adebowale A.
    Summar, Marshall
    Zackai, Elaine H.
    McDonald-McGinn, Donna M.
    Linguraru, Marius George
    Muenke, Maximilian
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2017, 173 (04) : 879 - 888